Who Paid My Doc
Rhonda Rountree
Registered Nurse, General Practice Macon, GA Nurse Practitioner
NPI 1205906955 CMS profile 10442222
400 Poplar St, Macon, GA 31201
General payments
$239
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Rhonda Rountree of Macon, GA is reported in the CMS Open Payments database as having received $239 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 62nd percentile of Registered Nurse, General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $239 | 2 |
Beside peers
- Rhonda Rountree
- Registered Nurse, General Practice median
- Middle half of Registered Nurse, General Practice
- National median
In program year 2025, general payments to Rhonda Rountree were reported at $239. Among 146 Registered Nurse, General Practice profiles paid that year, the median was $117 and the middle half received between $27 and $348.
Show as a table
| Year | Rhonda Rountree | Registered Nurse, General Practice median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $92 | $30–$313 | $132 |
| 2022 | $0 | $85 | $28–$243 | $149 |
| 2023 | $0 | $121 | $51–$290 | $160 |
| 2024 | $0 | $127 | $42–$316 | $164 |
| 2025 | $239 | $117 | $27–$348 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 74 drugsPart D claims
4,258
Drug cost
$200,706
Branded share of claims
14.6%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ozempic Semaglutide | Brand | 55 | $73,235 | |
| Farxiga Dapagliflozin Propanediol | Brand | 45 | $48,063 | |
| Eliquis Apixaban | Brand | 12 | $19,481 | |
| Januvia Sitagliptin Phosphate | Brand | 15 | $16,493 | |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | Brand | 14 | $3,815 | |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | Brand | 19 | $3,405 | |
| Albuterol Sulfate Hfa Albuterol Sulfate | Brand | 87 | $2,741 | |
| Novolog Flexpen Insulin Aspart | Brand | 14 | $2,728 | |
| Duloxetine Hcl | Generic | 38 | $2,441 | |
| Lantus Insulin Glargine,hum.Rec.Anlog | Brand | 11 | $2,030 |
The 10 drugs with the highest cost, of 74 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 476 Part D prescribers listed as Registered Nurse; they describe a distribution and say nothing about conduct.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Registered Nurse, General Practice in Georgia
Meagan Wilson
Registered Nurse, General Practice · Dawsonville, GA
Jana Ludwig
Registered Nurse, General Practice · Fayetteville, GA
Shannon Shockley
Registered Nurse, General Practice · Marietta, GA
Charlene Pugh
Registered Nurse, General Practice · Griffin, GA
Ruth Tuggle
Registered Nurse, General Practice · Columbus, GA
Pennica Mumford
Registered Nurse, General Practice · Savannah, GA
Related records
Registered Nurse, General Practice in Georgia
Practitioners in the same specialty and state, ranked by reported value.
All Registered Nurse, General Practice
Everyone recorded under this specialty, nationwide.
Doctors in Georgia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.